隐匿性甲状腺癌:1例病例报道和文献回顾

doi:10.6040/j.issn.1671-7554.0.2020.1148

摘要/Abstract

摘要： 目的探讨隐匿性甲状腺癌病灶隐匿的可能原因,分析隐匿性甲状腺癌的临床特点及相关的治疗方式。方法对我科1例隐匿性甲状腺癌(中央区淋巴结查见甲状腺癌病灶,而甲状腺癌病理未证实原发灶)患者进行病例讨论,并通过文献复习,分析总结隐匿性甲状腺癌的病灶可能的隐匿原因、分类、诊断及治疗。结果经分析病例并文献检索,隐匿性甲状腺癌常见病灶隐匿原因:异位甲状腺组织的恶变、病理检测手段的局限、癌细胞的退行性改变。隐匿性甲状腺癌诊断相对困难,需综合应用多元化诊断手段来提高确诊率,治疗方式为以手术为主的综合治疗。本例患者随访20个月,无疾病进展。结论了解各类隐匿性甲状腺癌的临床特征、病灶可能的隐匿原因、诊断方法、以及手术方式,可以提高隐匿性甲状腺癌的确诊率并改善预后。

关键词: 隐匿性甲状腺癌, 临床分类, 诊断, 治疗

Abstract: Objective To explore the possible causes, clinical characteristics and treatment of occult thyroid carcinoma. Methods The clinical data of a case of occult thyroid carcinoma treated in our department were retrospectively analyzed and literature was reviewed. The etiology, classification, diagnosis and treatment of this rare disease were summarized. Results The possible causes of occult thyroid carcinoma included malignant transformation of ectopic thyroid tissues, limitations of pathological detection and degenerative changes of cancer cells. This disease was difficult to diagnose, and comprehensive methods were necessary to establish the diagnosis. Surgery was the major treatment. During the follow-up of 20 months, there was no disease progression in this case. Conclusion Understanding the clinical features, possible causes, diagnostic methods and surgical methods of all subtypes of occult thyroid carcinoma can improve the diagnosis rate and prognosis.

Key words: Occult thyroid cancer, Clinical classification, Diagnosis, Treatment

中图分类号:

R736.1

柴佳威,朱坤兵,李亚琼,王甜甜. 隐匿性甲状腺癌:1例病例报道和文献回顾[J]. 山东大学学报 (医学版), 2021, 59(1): 83-87.

CHAI Jiawei, ZHU Kunbing, LI Yaqiong, WANG Tiantian. Occult thyroid carcinoma: a report of a rare case and review of literature[J]. Journal of Shandong University (Health Sciences), 2021, 59(1): 83-87.

参考文献

[1] Yang GC, LiVolsi VA, Baloch ZW. Thyroid microcarcinoma: fine-needle aspiration diagnosis and histologic follow-up[J]. Int J Surg Pathol, 2002, 10(2): 133-139.
[2] Boucek J, Kastner J, Skrivan J, et al. Occult thyroid carcinoma[J]. Acta Otorhinolaryngol Ital,2009,29(6):296-304.
[3] Izzard M, McIvor N, Chaplin J, et al. Neurological deficit as a presentation of occult metastatic thyroid carcinoma[J]. ANZ J Surg, 2006, 76(10): 953-956.
[4] Yamamoto Y, Maeda T, Izumi K, et al. Occult papillary carcinoma of the thyroid. A study of 408 autopsy cases[J]. Cancer, 1990, 65(5): 1173-1179.
[5] Yuen AP, Ho AC, Wong BY. Ultrasonographic screening for occult thyroid cancer[J]. Head Neck, 2011, 33(4): 453-457.
[6] Kwak JY. Indications for fine needle aspiration in thyroid nodules[J]. Endocrinol Metab, 2013, 28(2): 81.
[7] Pardal-de-Oliveira F, Vieira F. Occult papillary carcinoma of the thyroid gland with extensive osseous metastases: a case report with review of the literature[J]. Pathol Res Pract, 1999, 195(10): 711-714.
[8] Cavazza A, Roggeri A, Zini M, et al. Lymphangioleiomyomatosis associated with pulmonary metastasis from an occult papillary carcinoma of the thyroid: report of a case occurring in a patient without tuberous sclerosis[J]. Pathol-Res Pract, 2002, 198(12): 825-828.
[9] Lecumberri B, Alvarez-Escolá C, Martín-Vaquero P, et al. Solitary hemorrhagic cerebellar metastasis from occult papillary thyroid microcarcinoma[J]. Thyroid, 2010,20(5):563-567.
[10] Kushwaha JK, Sonkar AA, Goel MM, et al. Papillary carcinoma of thyroid arising from ectopic thyroid tissue inside branchial cleft cyst: a rare case[J]. Case Rep, 2012, 2012(jul06 1): bcr0220125783.
[11] Xu JJ, Kwan K, Fung K. Papillary thyroid carcinoma in a lateral neck cyst: primary of ectopic thyroid tissue versus cystic metastasis[J]. J Laryngol Otol, 2013, 127(7): 724-727.
[12] Liu H, Lv L, Yang K. Occult thyroid carcinoma: a rare case report and review of literature[J]. Int J Clin Exp Pathol, 2014,7(8):5210-5214.
[13] Herbowski L, Dobrzycki W. Incidental detection of unexpected neck lymphatic III level node metastasis from occult papillary thyroid carcinoma during cervical disc surgery: first literature report[J]. Endokrynologia Polska, 2020. doi:10.5603/ep.a2020.0031.
[14] Yamashita G, Kondo T, Okimura A, et al. Occult papillary thyroid carcinoma without detection of the primary tumor on preoperative ultrasonography or postoperative pathological examination: a case report[J]. Case Rep Oncol, 2020, 13(1): 105-112.
[15] Ito Y, Hirokawa M, Fukushima M, et al. Occult papillary thyroid carcinoma: diagnostic and clinical implications in the era of routine ultrasonography[J]. World J Surg, 2008, 32(9): 1955-1960.
[16] Yamamoto T, Tatemoto Y, Hibi Y, et al. Thyroid carcinomas found incidentally in the cervical lymph nodes: do they arise from heterotopic thyroid tissues?[J]. J Oral Maxillofac Surg, 2008, 66(12): 2566-2576.
[17] Liska J, Altanerova V, Galbavy S, et al. Thyroid tumors: histological classification and genetic factors involved in the development of thyroid cancer[J]. Endocr Regul, 2005, 39(3): 73-83.
[18] Ibrahim NBN, Milewski PJ, Gillett R, et al. Benign thyroid inclusions within cervical lymph nodes: an alarming incidental finding[J]. ANZ J Surg, 1981, 51(2): 188-189.
[19] Liska J, Altanerova V, Galbavy S, et al. Thyroid tumors: histological classification and genetic factors involved in the development of thyroid cancer[J]. Endocr Regul, 2005, 39(3): 73-83.
[20] Shinohara M, Harada T, Nakamura S, et al. Heterotopic salivary gland tissue in lymph nodes of the cervical region[J]. Int J Oral Maxillofac Surg, 1992, 21(3): 166-171.
[21] Ansari-Lari MA, Westra WH. The prevalence and significance of clinically unsuspected neoplasms in cervical lymph nodes[J]. Head Neck, 2003, 25(10): 841-847.
[22] Coleman SC, Smith JC, Burkey BB, et al. Long-standing lateral neck mass as the initial manifestation of well-differentiated thyroid carcinoma[J]. Laryngoscope, 2000, 110(2): 204.
[23] Elsheikh TM, Asa SL, Chan JK, et al. Interobserver and intraobserver variation among experts in the diagnosis of thyroid follicular lesions with borderline nuclear features of papillary carcinoma[J]. Am J Clin Pathol, 2008, 130(5): 736-744.
[24] Lloyd RV, Erickson LA, Casey MB, et al. Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma[J]. Am J Surg Pathol, 2004, 28(10): 1336-1340.
[25] Kapur U, Wojcik EM. Follicular neoplasm of the thyroid: vanishing cytologic diagnosis?[J]. Diagn Cytopathol, 2007, 35(8): 525-528.
[26] Sako H, Abe H, Kodama M, et al. Histological study of minute papillary carcinoma of the thyroid[J].The journal of the Japanese Practical Surgeon Society, 2009. doi: 10.3919/ringe1963.57.2088.
[27] Khoo ML, Ezzat S, Freeman JL, et al. Cyclin D1 protein expression predicts metastatic behavior in thyroid papillary microcarcinomas but is not associated with gene amplification[J]. J Clin Endocrinol Metab, 2002, 87(4): 1810-1813.
[28] Lantsov D, Meirmanov S, Nakashima M, et al. Cyclin D1 overexpression in thyroid papillary microcarcinoma: its association with tumour size and aberrant beta-catenin expression[J]. Histopathology, 2005, 47(3): 248-256.
[29] Londero SC, Godballe C, Krogdahl A, et al. Papillary microcarcinoma of the thyroid gland: is the immunohistochemical expression of cyclin D1 or galectin-3 in primary tumour an indicator of metastatic disease?[J]. Acta Oncol, 2008, 47(3): 451-457.
[30] Zou M, Al-Baradie RS, Al-Hindi H, et al. S100A4(Mts1)gene overexpression is associated with invasion and metastasis of papillary thyroid carcinoma[J]. Br J Cancer, 2005, 93(11): 1277-1284.
[31] Min HS, Choe G, Kim S, et al. S100A4 expression is associated with lymph node metastasis in papillary microcarcinoma of the thyroid[J]. Mod Pathol, 2008, 21(6): 748-755.
[32] 刘永刚, 张蕾. 102例颈部肿块的临床分析[J]. 内蒙古医学杂志, 2012, 44(11): 1353-1354.
[33] Liu H, Lv L, Yang K. Occult thyroid carcinoma: a rare case report and review of literature[J]. Int J Clin Exp Pathol, 2014,7(8):5210-5214.
[34] Medas F, Canu G, Cappellacci F, et al. Prophylactic central lymph node dissection improves disease-free survival in patients with intermediate and high risk differentiated thyroid carcinoma: a retrospective analysis on 399 patients[J]. Cancers, 2020, 12(6): 1658.
[35] Hughes DT, White ML, Miller BS, et al. Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancer[J]. Surgery, 2010, 148(6): 1100-1106.

相关文章 15

[1]	李波波李道堂刘曙光王兴武. 食管癌患者血清中DKK-1的表达[J]. 山东大学学报(医学版), 2209, 47(6): 58-61.
[2]	徐平于国放李霞. 不同类型甲状腺上动脉PSV对Graves病与桥本氏甲状腺炎鉴别诊断的价值[J]. 山东大学学报(医学版), 2209, 47(6): 62-64.
[3]	王欣，邢春燕，杨艳平. 血清磷酸丙酮酸水合酶检测对诊断侵袭性白念珠菌感染的临床价值[J]. 山东大学学报(医学版), 2209, 47(6): 92-94.
[4]	巩性军，吴树明，张供，李守先，庞昕焱. 无顶冠状静脉窦综合征的诊断和外科治疗[J]. 山东大学学报(医学版), 2209, 47(6): 129-.
[5]	山东省医学会心电学分会山东省医学伦理学学会心电学分会. 心电图报告规范化书写专家共识(2026)[J]. 山东大学学报 (医学版), 2026, 64(4): 1-7.
[6]	孙红林,管玉强,于培儒,李磊,杜庆霞,丁浩. 支架植入治疗儿童主动脉缩窄并高血压的可行性及近中期疗效[J]. 山东大学学报 (医学版), 2026, 64(4): 58-62.
[7]	林明霞,刘桂斌,马燕花,连曌昱,任洋洋. ATP酶铜转运蛋白α介导的铜死亡途径及在肿瘤治疗中的价值[J]. 山东大学学报 (医学版), 2026, 64(4): 117-124.
[8]	樊呈敏,宋静雨,于书彦,毛雪琴. 舒肝解郁胶囊治疗青少年抑郁障碍的研究进展[J]. 山东大学学报 (医学版), 2026, 64(3): 17-23.
[9]	中国医师协会骨科医师分会智能骨科学组,中华预防医学会脊柱疾病预防与控制专业委员会脊柱脊髓损伤疾病预防与控制学组. 人工智能脊柱退变影像学测量位点与标注专家共识(2025)[J]. 山东大学学报 (医学版), 2026, 64(2): 1-10.
[10]	李雪凯,孙淋涵,刘端瑞,倪阳. 乳酸化修饰在肿瘤炎癌进程中的功能与机制研究进展[J]. 山东大学学报 (医学版), 2025, 63(9): 65-76.
[11]	罗淇,王霞,姜孟. 脑功能网络分析在失语症诊疗中的应用:病理机制分析、临床诊断与疗效评价[J]. 山东大学学报 (医学版), 2025, 63(8): 111-126.
[12]	河南省生物医学工程学会立体心电图专业委员会,中国医药教育协会心电学专业委员会,山东中医药学会心电学专业委员会,青岛市医学会心电生理与起搏专科分会,全国医药技术市场协会远程心脏专业委员会. 心电向量图诊断标准规范化专家共识(2025)[J]. 山东大学学报 (医学版), 2025, 63(7): 1-10.
[13]	刘保国,宋翔,赵晓文,毛亚丽. 血清STAT5B、NKAIN1 mRNA检测在乳腺癌中的应用价值[J]. 山东大学学报 (医学版), 2025, 63(7): 68-74.
[14]	祝永才,谢艳,齐秋晨,李培龙,王传新,杜鲁涛. 基于外周血单个核细胞ATM基因甲基化的联合模型在胰腺癌早期诊断中的价值[J]. 山东大学学报 (医学版), 2025, 63(6): 78-88.
[15]	国科,陈绪军,郑宝石,施超,黄克力,曹勇,陈军,吴东凯,张晓慎,罗俊辉,申林,莫绪明,杨岷,王晓武,雷印胜,田茂州,王振东,孟自力,孙忠东,李有金,陆辉辉,孟春营,高峰,陈黔苏,郭能瑞,柳德斌,张楠,林宇,陈文生,宋保国,方智,王海晨,廖晓波,徐朝军. 快通道拔管在全动脉冠脉旁路移植术的多中心临床效果[J]. 山东大学学报 (医学版), 2025, 63(5): 26-32.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed